Evaluation of biomarker changes after administration of various neoadjuvant chemotherapies in breast cancer. - Wikidata - awgldk - TriplyDB

Evaluation of biomarker changes after administration of various neoadjuvant chemotherapies in breast cancer.

Evaluation of biomarker changes after administration of various neoadjuvant chemotherapies in breast cancer.

http://www.wikidata.org/entity/Q35145309

about

Discordance in Immunohistochemical Status of Breast Cancer Post Neoadjuvant Chemotherapy.

P2860

Q53976122-580D636B-E0E3-426D-824F-CD24BCD33D1A

P2860

Evaluation of biomarker changes after administration of various neoadjuvant chemotherapies in breast cancer.

http://www.wikidata.org/entity/Q35145309

description

2015 nî lūn-bûn

@nan

2015 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Evaluation of biomarker change ...... emotherapies in breast cancer.

@ast

Evaluation of biomarker change ...... emotherapies in breast cancer.

@en

type

label

Evaluation of biomarker change ...... emotherapies in breast cancer.

@ast

Evaluation of biomarker change ...... emotherapies in breast cancer.

@en

prefLabel

Evaluation of biomarker change ...... emotherapies in breast cancer.

@ast

Evaluation of biomarker change ...... emotherapies in breast cancer.

@en

P1433

Q35145309-191C86E8-2ADC-4922-A265-569EA08240B5

P1476

Q35145309-CE281B5E-8B8B-4FF7-9BD2-5B41DC54F74A

P2093

Q35145309-163C871D-CDF3-40E6-A8DC-0FF615A95204

Q35145309-4B2228B9-28B6-47C2-AC55-0230A5E60BEB

Q35145309-5AA608AF-EAC5-45ED-B068-DB176E423954

Q35145309-76623A10-E056-46B5-A28F-52085DD24F94

Q35145309-80B45433-C76D-4566-A150-68773A26731D

Q35145309-A78A0E1B-DEF3-42C3-A2EF-725730AE9E85

Q35145309-B722292A-F935-4DAB-B8F7-67AF039E9694

Q35145309-D05E1D24-A493-4A52-A036-1693F8816528

Q35145309-F16D19B4-E806-4179-AD40-7D15B68F68F7

Q35145309-F80CB4DA-E07E-4A1A-B804-8D9F95A56B97

P2860

Q35145309-15A80AF2-6148-4F99-9F87-4256FB32B93B

Q35145309-16830CD7-182D-4573-82EC-E5FDC4B50FB9

Q35145309-1F39124B-4F66-4FF9-8D01-88B0BA7177CC

Q35145309-3350BC31-F16C-45EE-8F6A-3C3819EB548F

Q35145309-5AFB67DD-51BE-49D2-A40F-04D582B30231

Q35145309-6F67C536-D16D-437D-ACE6-6130375CFC2E

Q35145309-724490F6-828A-46E0-9925-CB12EFF5FC50

Q35145309-73DF4B84-605C-46B4-9FF4-1ABDC484C233

Q35145309-7D537BD5-1F11-4A27-A25D-5BB229FE222D

Q35145309-7FF830B1-A785-4185-B837-E4EB4B3D3AE0

P304

Q35145309-20E0EA20-C408-4D5A-AAF2-3EAD51A7EA4B

P31

Q35145309-AF364E55-FD67-4C90-8CD8-163F6E5A2BA8

P433

Q35145309-E41542E1-3B48-4985-A1CB-87F066ACCB8D

P478

Q35145309-FEC9A0F1-DD70-4562-94DF-BC8CB7B646F7

P577

Q35145309-D4A28732-618E-4761-BD8F-873C397E4F45

P698

Q35145309-34BFED20-D034-41AB-8F33-7734C73441BE

P921

Q35145309-3792580D-8D2E-4488-99D9-2664E51958A8

P932

Q35145309-B435A2B1-82B7-46DA-A878-BBEE63815808

P1433

International Journal of Clinical and Experimental Pathology

P1476

Evaluation of biomarker change ...... emotherapies in breast cancer.

@en

P2093

Butong Ding

http://www.w3.org/2001/XMLSchema#string

Cun Liu

http://www.w3.org/2001/XMLSchema#string

Guangchao Jin

http://www.w3.org/2001/XMLSchema#string

Guohui Ma

http://www.w3.org/2001/XMLSchema#string

Jun Gao

http://www.w3.org/2001/XMLSchema#string

Liansheng Chen

http://www.w3.org/2001/XMLSchema#string

Shijin Xuan

http://www.w3.org/2001/XMLSchema#string

Xianqiang Liu

http://www.w3.org/2001/XMLSchema#string

Xingsong Tian

http://www.w3.org/2001/XMLSchema#string

Yu Han

http://www.w3.org/2001/XMLSchema#string

P2860

Neoadjuvant chemotherapy for locally advanced breast cancer results in alterations in preoperative tumor marker status.

HER-2/neu expression as a predictor of response to neoadjuvant docetaxel in patients with operable breast carcinoma.

Primary chemotherapy in breast invasive carcinoma: predictive value of the immunohistochemical detection of hormonal receptors, p53, c-erbB-2, MiB1, pS2 and GST pi.

The relationship of the neo-angiogenic marker, endoglin, with response to neoadjuvant chemotherapy in breast cancer.

Evaluation of ER, PgR, HER-2 and Ki-67 as predictors of response to neoadjuvant anthracycline chemotherapy for operable breast cancer

Breast cancer response to neoadjuvant chemotherapy: predictive markers and relation with outcome.

Change in the hormone receptor status following administration of neoadjuvant chemotherapy and its impact on the long-term outcome in patients with primary breast cancer

Discordances in ER, PR and HER2 receptors after neoadjuvant chemotherapy in breast cancer.

The effect of neoadjuvant chemotherapy on histologic grade, hormone receptor status, and HER2/neu status in breast carcinoma.

Clinical significance of Ki-67 in neoadjuvant chemotherapy for primary breast cancer as a predictor for chemosensitivity and for prognosis.

P304

914-921

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25755795

http://www.w3.org/2001/XMLSchema#string

P921

P932

4348938

http://www.w3.org/2001/XMLSchema#string